On April 16, 2026, Vir Biotechnology, Inc. announced the closing of its global collaboration and licensing agreement with Astellas for VIR-5500 in metastatic prostate cancer, securing a US$240,000,000 ...

The National Universities Commission (NUC) has granted full accreditation to the Biotechnology programme at McPherson University, Lagos-Ibadan Expressway, Ogun State, marking a significant milestone ...

The biotechnical research at the HudsonAlpha Institute for Biotechnology is once again in the national spotlight. The ...

Central Ohio is a growing U.S. biotech hub because of decades of efforts, the head of a national trade group says.

Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the first quarter ended March 31, 2026. First ...

Transaction Positions XTL at the Forefront of the Rapidly Expanding Global Psychedelic Therapeutics Market Following Major U.S. Regulatory ...

Nautilus Biotechnology (NASDAQ:NAUT) reported first-quarter 2026 results and highlighted progress toward its planned ...

BioDuro has entered a strategic partnership with CTI Biotechnology to build an integrated preclinical development platform ...

AstraZeneca’s $4.5 billion investment in Albemarle County is set to create 600 jobs and strengthen Charlottesville’s biotech ...

An engineered E. coli strain survived after one amino acid was designed out of many of its ribosomal proteins—an early test ...

When we treat cancer patients, their disease can overcome treatment through its innate capacity to adapt. This is at the ...

Earlier today, Nautilus Biotechnology released financial results for the quarter ended March 31, 2026. If you haven't received this news release or if you'd like to be added to the company's ...